Quaker Chemical (NYSE:KWR) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday. The firm currently has a $176.00 price target on the specialty chemicals company’s stock. Zacks Investment Research‘s price target points to a potential upside of 11.82% from the stock’s current price.
According to Zacks, “Quaker Chemical Corporation develops, produces and markets a range of formulated chemical specialty products for various heavy industrial and manufacturing applications and, in addition, offers and markets chemical management services (CMS). The Company operates in three segments: Metalworking process chemicals, Coatings and Other chemical products. The Metalworking process chemicals segment includes industrial process fluids for various heavy industrial and manufacturing applications. Coatings segment includes temporary and permanent coatings for metal and concrete products and chemical milling maskants. “
A number of other equities research analysts also recently weighed in on the stock. TheStreet downgraded shares of Quaker Chemical from a “b” rating to a “c+” rating in a research report on Monday, March 5th. B. Riley set a $165.00 price objective on shares of Quaker Chemical and gave the company a “hold” rating in a research report on Thursday, March 1st. Finally, ValuEngine downgraded shares of Quaker Chemical from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $164.75.
Quaker Chemical (NYSE:KWR) last announced its quarterly earnings data on Wednesday, February 28th. The specialty chemicals company reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.01. Quaker Chemical had a net margin of 2.47% and a return on equity of 15.48%. The business had revenue of $211.10 million during the quarter, compared to the consensus estimate of $208.07 million. During the same quarter in the prior year, the firm earned $1.26 EPS. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. research analysts expect that Quaker Chemical will post 5.46 earnings per share for the current year.
In other Quaker Chemical news, CEO Michael F. Barry sold 1,250 shares of the company’s stock in a transaction dated Thursday, March 1st. The shares were sold at an average price of $160.13, for a total value of $200,162.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Adrian Steeples sold 1,957 shares of the company’s stock in a transaction dated Tuesday, March 6th. The stock was sold at an average price of $150.34, for a total transaction of $294,215.38. Following the completion of the transaction, the director now owns 5,101 shares of the company’s stock, valued at approximately $766,884.34. The disclosure for this sale can be found here. In the last 90 days, insiders sold 9,186 shares of company stock valued at $1,399,442. 3.60% of the stock is owned by insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of KWR. Carillon Tower Advisers Inc. bought a new position in Quaker Chemical in the 4th quarter worth about $103,056,000. Ranger Investment Management L.P. grew its position in Quaker Chemical by 141.2% in the 4th quarter. Ranger Investment Management L.P. now owns 214,455 shares of the specialty chemicals company’s stock worth $32,338,000 after purchasing an additional 125,543 shares during the last quarter. JPMorgan Chase & Co. grew its position in Quaker Chemical by 17.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 638,073 shares of the specialty chemicals company’s stock worth $95,041,000 after purchasing an additional 94,167 shares during the last quarter. Cortina Asset Management LLC bought a new position in Quaker Chemical in the 4th quarter worth about $8,602,000. Finally, BlackRock Inc. grew its position in Quaker Chemical by 3.2% in the 4th quarter. BlackRock Inc. now owns 1,646,283 shares of the specialty chemicals company’s stock worth $248,242,000 after purchasing an additional 50,506 shares during the last quarter. Hedge funds and other institutional investors own 92.22% of the company’s stock.
About Quaker Chemical
Quaker Chemical Corporation is a provider of process fluids, chemical specialties, and technical expertise to a range of industries, including steel, aluminum, mining, aerospace, tube and pipe, cans and others. The Company’s segments include North America, Europe, Middle East and Africa (EMEA), Asia/Pacific and South America.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Quaker Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quaker Chemical and related companies with MarketBeat.com's FREE daily email newsletter.